US2020316016A1PendingUtilityA1

Compositions and methods related to cannabinoids, terpenoids and essential oils

45
Individually held — no corporate assignee on recordPriority: Jul 16, 2018Filed: Jun 23, 2020Published: Oct 8, 2020
Est. expiryJul 16, 2038(~12 yrs left)· nominal 20-yr term from priority
Inventors:John C. Gustin
A61K 31/658A61K 47/44A61K 45/06A61K 36/537A61K 31/047A61K 36/258A61K 36/53A61K 9/007A61K 9/0014A61K 36/84A61K 31/352
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides cannabinoid and terpenoid compositions, among others, and methods of use including as medicines, supplements and nutraceuticals.

Claims

exact text as granted — not AI-modified
What is claimed is; 
     
         1 . A composition, comprising: a combination of one or more synthetic cannabinoids and one or more synthetic terpenoids; wherein the composition substantially lacks a tetrahydrocannabinol. 
     
     
         2 . The composition of  claim 1 , further including a pharmaceutically acceptable excipient. 
     
     
         3 . The composition of  claim 1 , wherein the one or more terpenoids includes a myrcene compound. 
     
     
         4 . The composition of  claim 1 , wherein the one or more cannabinoids are present in an amount of 5% or greater by weight and the one or more terpenoids are present in an amount of 5% or greater by weight. 
     
     
         5 . The composition of  claim 1 , wherein the one or more cannabinoids are present in an amount of 10 mg or more and the one or more terpenoids are present in an amount of 10 mg or more. 
     
     
         6 . A composition, comprising: one or more cannabinoid compounds and one or more essential oils of a plant, wherein the formulation substantially lacks a tetrahydrocannabinol (THC) and wherein the composition includes one of, or any combination of the essential oil of: howood, rosewood, coriander, linaloe, sweet basil linalool type, thyme linalool type and cardamom. 
     
     
         7 . The composition of  claim 6 , including a myrcene compound. 
     
     
         8 . The composition of  claim 6 , including a cannabidiol (CBD) compound. 
     
     
         9 . The composition of  claim 8 , including a caryophyllene compound. 
     
     
         10 . The composition of  claim 6 , including a cannabidiol compound and an essential oil of a ginseng plant, a sage plant or both. 
     
     
         11 . The composition of  claim 6 , wherein the cannabinoid is one or more of a cannabidiol compound, a cannabinol compound and a cannabigerol compound. 
     
     
         12 . A composition, comprising: one or more cannabinoids and at least one essential oil obtained from a valerian plant, a lavender plant or both, wherein the cannabinoid is one or more of a cannabidiol compound, a cannabinol compound, and a cannabigerol compound, or any combination thereof. 
     
     
         13 . The composition of  claim 12 , wherein the one or more cannabinoids are synthetic cannabinoids. 
     
     
         14 . The composition of  claim 12 , including one cannabinoid being the cannabinol compound and one essential oil being from the valerian plant or the lavender plant. 
     
     
         15 . The composition of  claim 12 , including one cannabinoid being the cannabinol compound and one essential oil being from the valerian plant or the lavender plant. 
     
     
         16 . The composition of  claim 12 , including one cannabinoid being the cannabigerol compound and one essential oil being from the valerian plant or the lavender plant. 
     
     
         17 . A composition, comprising: one or more cannabinoids and a caryophyllene compound, wherein the cannabinoid is one or more of a cannabidiol compound, a cannabinol compound, and a cannabigerol compound, or any combination thereof. 
     
     
         18 . The composition of  claim 17 , wherein the one or more cannabinoids are synthetic cannabinoids. 
     
     
         19 . A method of alleviating a symptom of a pain, an inflammation or both in a subject in need thereof, comprising: administering an effective amount of a composition including a cannabinoid compound and a terpenoid compound, wherein the composition substantially lacks a tetrahydrocannabinol compound. 
     
     
         20 . The method of  claim 19 , wherein the composition further includes a pharmaceutically acceptable excipient. 
     
     
         21 . The method of  claim 19 , wherein the cannabinoid compound includes one or more of a cannabidiol compound, a cannabinol compound, and a cannabigerol compound or any combination thereof. 
     
     
         22 . The method of  claim 19 , wherein the cannabinoid compound is the cannabinol compound, the cannabigerol compound or both. 
     
     
         23 . The method of  claim 19 , having a synthetic cannabinoid compound. 
     
     
         24 . The method of  claim 19 , having a synthetic terpenoid compound. 
     
     
         25 . The method of  claim 19 , having a synthetic cannabinoid compound and a synthetic terpenoid compound. 
     
     
         26 . The method of  claim 19 , including a caryophyllene compound, a myrcene compound or both.

Join the waitlist — get patent alerts

Track US2020316016A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.